Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
956697-53-3
Purity
95%
Sonidegib is an antineoplastic agent used for the treatment of locally advanced recurrent basal cell carcinoma following surgery and radiation therapy. Sonidegib effectively inhibits the regulator called smoothened, preventing the hedgehog pathway from functioning.
Properties
Name
Sonidegib
Smiles
C[C@H]1CN(C[C@@H](C)O1)C=2C=CC(NC(=O)C=3C=CC=C(C3C)C=4C=CC(OC(F)(F)F)=CC4)=CN2
Targets
Please log in to see this information
SDS
Erismodegib | LDE225 | NVP-LDE225 | odomzo | sonidegib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$48
2 mg
$50
5 mg
$51
10 mg
$58
15 mg
$64
20 mg
$69
25 mg
$77
30 mg
$82
35 mg
$90
40 mg
$98
45 mg
$106
50 mg
$113
75 mg
$131
100 mg
$141
Quantity
1
Total amount
$ 51
Erismodegib | LDE225 | NVP-LDE225 | odomzo | sonidegib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1218778-77-8
0